The research department at SSTAR just celebrated enrolling the 100th participant into the Retention phase of our RDD study. The purpose of the Retention phase is to test treatment approaches, including medications, to help people with opioid use disorder. SSTAR is the first out of the 20 organizations across the country working on this study to have enrolled 100 participants.
 
[search]